GAOMA Therapeutics
GHP News Excellence Award for Research and Innovation
<p>GAOMA Therapeutics is a French biotech company founded in 2019, with the ambition to develop lipids derivatives as innovative drug-candidates.<br />
The company’s first lead molecule, GAO-3-02, aims to address epilepsy and cognitive disorders by targeting neuroinflammation and brain plasticity.</p>